---
title: "\"Performance\" GRANDPHARMA's annual net profit is 1.241 billion yuan, a decrease of 49.7%, with a final dividend of 16.9 cents"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280663459.md"
description: "GRANDPHARMA announced its 2025 annual performance, with revenue of 12.283 billion yuan, an increase of 5.5% year-on-year; gross profit of 6.78 billion yuan, a slight increase of 0.6%. It recorded a net profit of 1.241 billion yuan, a decline of 49.7%, with earnings per share of 35.44 cents. The final dividend is 16.9 Hong Kong cents, compared to 26 Hong Kong cents in the same period last year"
datetime: "2026-03-26T16:17:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280663459.md)
  - [en](https://longbridge.com/en/news/280663459.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280663459.md)
---

# "Performance" GRANDPHARMA's annual net profit is 1.241 billion yuan, a decrease of 49.7%, with a final dividend of 16.9 cents

GRANDPHARMA (00512.HK) announced its performance for the fiscal year 2025, with revenue of 12.283 billion yuan, an increase of 5.5% year-on-year; gross profit of 6.78 billion yuan, a slight increase of 0.6%. It recorded a net profit of 1.241 billion yuan, a decline of 49.7%, with earnings per share of 35.44 cents. The final dividend is 16.9 Hong Kong cents, compared to 26 Hong Kong cents in the same period last year

### Related Stocks

- [00512.HK](https://longbridge.com/en/quote/00512.HK.md)

## Related News & Research

- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy](https://longbridge.com/en/news/287059695.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)